Epigenetics Market Is Anticipated To Reach $16.31 Billion By 2022: Grand View Research, Inc.
The global epigenetics market is expected to reach USD 16.31
billion by 2022, according to a new report by Grand View Research, Inc. Growing
worldwide prevalence of cancer and other diseases with epigenetic modification
base is expected to drive market growth during the forecast period.
Diagnostic companies are coming up with new products such as
antibodies specific for the detection of modifications and new upgraded kits
for easy and efficient detection of biomarkers. This is expected to attract
pharmaceutical companies to collaborate for the development of therapeutic
drugs.
Presence of pipeline drugs and their expected
commercialization is anticipated to boost penetration rates over the forecast
period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was
approved by the FDA for use in combination with Folfiri for the treatment of
patients with metastatic colorectal cancer.
Technology advancements in the field of epigenetics
especially pertaining to the detection of methylation markers related to cancer
development is expected to improve usage rates during the forecast period. For
instance, Epi proLung BL Reflex Assay by Epigenomics helps in the diagnosis of
lung cancer by determining methylation of SHOX2 biomarker gene.
Browse full research report on Epigenetics Market: http://www.grandviewresearch.com/industry-analysis/epigenetics-market
Further key findings from the report suggest:
- Epigenetic reagents was the largest market valued at over USD 1.2 billion in 2014 owing to the increasing amount of R&D investments and high consumption rates. Kits are expected to gain rapid growth in demand due to the increasing need of rapid and accurate detection techniques.
- DNA
methylation was the largest technology segment accounting for over 47.0%
revenue in 2014. The introduction of technological advancement such as
Methylation Sensitive PCR (MSP) and rapid adoption of these products to
improve diagnostics efficiency are some factors attributing for its
largest share.
- Oncology
was the largest application market, with revenue valued at over USD 2.75
billion. Growing prevalence of cancer with epigenetic modification base
and strong product pipeline are some factors attributing to its market
position.
- Non
oncology segment is anticipated to register the fastest growth of over
20.0% during the forecast period. The segment is dominated by metabolic
diseases owing to, the growing base of population suffering from diabetes
and organ failure and increasing prevalence of sedentary lifestyle.
- North
America was observed to be the largest regional epigenetics market
accounting for over 38.0% of the overall revenue, due to factors such as
the increasing cancer prevalence, increasing amount of funding for
R&D, growing collaborations between large pharmaceutical firms for
development of improved therapeutics, high patient awareness levels.
- The
Asia Pacific market is estimated to witness lucrative growth over the
forecast period owing to, the presence of large prevalence of target
diseases and high unmet medical needs
- Some
key players of the epigenetics market include Illumina, Abcam, Diagenode,
Thermo Fisher Scientific, Merck, Zymo research, Qiagen, CellCentric Ltd,
Chroma Therapeutics Ltd, Eisai Co. Ltd, Novartis International AG, Oncolys
Biopharma Inc., Syndax Pharmaceuticals, Inc., Valirx Plc and Sigma-Aldrich
Corporation.
- Extensive
R&D initiatives aimed at the development of novel drugs and the
presence of strong product pipeline is expected to further boost market
growth over the forecast period.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global epigenetics
market on the basis of product, technology, application and region:
Epigenetics Product Outlook (Revenue, USD Million, 2015 –
2022)
- Reagents
- Kits
- Instruments
- Enzymes
- Services
Epigenetics Technology Outlook (Revenue, USD Million,
2015 – 2022)
- DNA
Methylation
- Histone
Methylation
- Histone
Acetylation
- Large
noncoding RNA
- MicroRNA
Modification
- Chromatin
structures
Epigenetics Application Outlook (Revenue, USD Million,
2015 – 2022)
- Oncology
- Solid
Tumors
- Liquid
Tumors
- Non
Oncology
- Inflammatory
Diseases
- Metabolic
Diseases
- Infectious
Diseases
- Cardiovascular
Diseases
Epigenetics Market Regional Outlook(Revenue, USD
Million, 2015 – 2022)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- Mexico
- Middle
East and Africa (MEA)
- South
Africa
Access press release of this research report by Grand
View Research: http://www.grandviewresearch.com/press-release/global-epigenetics-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports,
customized research reports, and consulting services. To help clients make
informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
For more information:
www.grandviewresearch.com
Comments
Post a Comment